Multidose Drug Dispensing in Community Healthcare Settings for Patients With Multimorbidity and Polypharmacy.

IF 1.7 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES
Adela Martín-Oliveros, Javier Plaza Zamora, Alessandro Monaco, Javier Anitua Iriarte, Jessica Schlageter, Danute Ducinskiene, Shaantanu Donde
{"title":"Multidose Drug Dispensing in Community Healthcare Settings for Patients With Multimorbidity and Polypharmacy.","authors":"Adela Martín-Oliveros, Javier Plaza Zamora, Alessandro Monaco, Javier Anitua Iriarte, Jessica Schlageter, Danute Ducinskiene, Shaantanu Donde","doi":"10.1177/00469580241274268","DOIUrl":null,"url":null,"abstract":"<p><p>Multidose drug dispensing (MDD) is the dispensing of different drugs in dose bags containing one, some, or all units of medicine that a patient needs to take at specific times. The aim of this narrative review is to provide an overview of the literature describing the use of MDD systems in community healthcare settings in patients with multimorbidity and polypharmacy. A literature search identified 14 studies examining adherence, medication knowledge, quality of drug prescription (including inappropriate drug use, drug-drug interactions), medication incidents, and drug changes after MDD initiation, as well as healthcare professional (HCP) and patient perspectives. There are limited data on MDD in community healthcare settings, particularly on outcomes such as adherence. Studies are mostly from Northern Europe. Patients selected for MDD are more likely to be older, female, cognitively impaired, and have a higher number of disease diagnoses and drugs than those who do not receive drugs through MDD. MDD is generally initiated for patients who have decreased capacity for medication management. Several advantages of MDD have been reported by patients and HCPs, and studies indicate that MDD can be improved by medication review, defining clear roles and responsibilities of HCPs in the medication management chain, and comprehensive follow-up of patients. Future development, implementation, and assessment of MDD systems in community healthcare should be designed in collaboration with HCPs and patients, to identify ways to optimize the systems and improve patient outcomes.</p>","PeriodicalId":54976,"journal":{"name":"Inquiry-The Journal of Health Care Organization Provision and Financing","volume":"61 ","pages":"469580241274268"},"PeriodicalIF":1.7000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11526267/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inquiry-The Journal of Health Care Organization Provision and Financing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00469580241274268","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Multidose drug dispensing (MDD) is the dispensing of different drugs in dose bags containing one, some, or all units of medicine that a patient needs to take at specific times. The aim of this narrative review is to provide an overview of the literature describing the use of MDD systems in community healthcare settings in patients with multimorbidity and polypharmacy. A literature search identified 14 studies examining adherence, medication knowledge, quality of drug prescription (including inappropriate drug use, drug-drug interactions), medication incidents, and drug changes after MDD initiation, as well as healthcare professional (HCP) and patient perspectives. There are limited data on MDD in community healthcare settings, particularly on outcomes such as adherence. Studies are mostly from Northern Europe. Patients selected for MDD are more likely to be older, female, cognitively impaired, and have a higher number of disease diagnoses and drugs than those who do not receive drugs through MDD. MDD is generally initiated for patients who have decreased capacity for medication management. Several advantages of MDD have been reported by patients and HCPs, and studies indicate that MDD can be improved by medication review, defining clear roles and responsibilities of HCPs in the medication management chain, and comprehensive follow-up of patients. Future development, implementation, and assessment of MDD systems in community healthcare should be designed in collaboration with HCPs and patients, to identify ways to optimize the systems and improve patient outcomes.

社区医疗机构为多病症和多重用药患者配发多剂量药物。
多剂量配药(MDD)是指将不同的药物装在剂量袋中进行配药,剂量袋中装有患者在特定时间需要服用的一种、一些或所有单位的药物。本综述旨在概述在社区医疗机构中对多病症和多重用药患者使用多剂量配药系统的文献。通过文献检索,我们发现了 14 项研究,这些研究探讨了 MDD 启动后的依从性、用药知识、药物处方质量(包括用药不当、药物间相互作用)、用药事故和药物更换,以及医护人员(HCP)和患者的观点。有关社区医疗机构中 MDD 的数据有限,尤其是有关依从性等结果的数据。研究大多来自北欧。与未通过 MDD 接受药物治疗的患者相比,被选中接受 MDD 治疗的患者更有可能是老年人、女性、认知功能受损者,并且有更多的疾病诊断和药物。MDD 通常针对药物管理能力下降的患者。患者和医疗保健人员报告了 MDD 的一些优点,研究表明,通过药物审查、明确医疗保健人员在药物管理链中的角色和责任以及对患者进行全面随访,可以改善 MDD。未来在社区医疗中开发、实施和评估 MDD 系统时,应与医护人员和患者合作,找出优化系统和改善患者预后的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
0.00%
发文量
192
审稿时长
>12 weeks
期刊介绍: INQUIRY is a peer-reviewed open access journal whose msision is to to improve health by sharing research spanning health care, including public health, health services, and health policy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信